logo
Plus   Neg
Share
Email
Comment

Valeant Pharma To Acquire Certain Assets From Atlantis Pharma - Quick Facts

Valeant Pharmaceuticals International Inc. (VRX,VRX.TO) announced that it has signed an agreement to acquire certain assets from Atlantis Pharma, a branded generics pharmaceutical company located in Mexico with a broad product portfolio, including products in the gastro, analgesics and anti-inflammatory therapeutic categories, for approximately $71 million.

The acquired assets' total revenue in 2011 was approximately $26 million and is expected to deliver double digit growth in 2012. The transaction is expected to close in the second quarter, subject to certain closing conditions including regulatory approvals, and is expected to be immediately accretive.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Citigroup Inc. on Tuesday reported a loss for the fourth quarter, reflecting the impact of a non-cash charge of $22 billion due to the recent U.S. tax reform that more than offset an increase in revenues. However, adjusted earnings per share for the quarter beat analysts' estimates, while revenues were in line with expectations. Shares of BP Plc were losing around 2 percent in the morning trading in London after the British energy giant said Tuesday that it now expects to take a post-tax non-operating charge of around $1.7 billion in its fourth quarter for Deepwater Horizon settlement program. BlackBerry Ltd. has introduced a new a cloud-based cybersecurity program that will scan automakers' software for threats amid increased concerns about hacking in Internet-connected cars. BlackBerry Jarvis, the transformational software cybersecurity product, helps carmakers detect security flaws in software before it goes into their vehicles.
comments powered by Disqus
Follow RTT